SightfileU.S. market data from official filings

Companies › FHTX

FOGHORN THERAPEUTICS INC (FHTX)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001822462 · EDGAR filings · Updated 2026-06-25

FOGHORN THERAPEUTICS INC (FHTX) has reported institutional ownership of 75.7%, with 105 institutional managers holding positions valued at $212.4M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01).

Institutional ownership
75.7%
Institutional managers
105
Reported 13F value
$212.4M
Insider activity
4 trans.
$0 net flat
Data flags
1 active
from SEC filings

Latest updates

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, FOGHORN THERAPEUTICS INC has 105 institutional holders and institutional ownership of 75.7%.

Insider activity

Insiders reported 4 transactions (0 buys, 0 sells) across 1 reporting insiders, with a net reported value of $0.

Data flags from SEC filings

Active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), most recently filed 2025-01-24 (recurring since 2025-01-24) — source filing. The authoritative details are those stated in the filing itself.

Related companies

CLIMB BIO INC (CLYM) · ALTIMMUNE INC (ALT) · CANDEL THERAPEUTICS INC (CADL) · NAUTILUS BIOTECHNOLOGY INC (NAUT) · KEROS THERAPEUTICS INC (KROS) · OPUS GENETICS INC (IRD)

See full history, cross-references and alerts on Sightfile
Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-06-25.